BRIANNA SCHAFFER: Open Payments
NPI 1700356334 · VILLISCA, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$252 in 12 payments from 9 companies in 2025. Trend: 2023 $165 · 2024 $169 · 2025 $252
Food & beverage: $252
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $55 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Axsome Therapeutics, Inc. | 1 | $32 |
| ABBVIE INC. | 2 | $29 |
| Lundbeck LLC | 1 | $24 |
| Novo Nordisk Inc | 1 | $23 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
Products named: CAPLYTA, Auvelity, REXULTI, Ozempic, JOURNAVX, Kerendia, UBRELVY, VRAYLAR.
Industry payments across IA — which companies pay providers there.
